These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5104497)

  • 1. Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen.
    Costall B; Olley JE
    Neuropharmacology; 1971 May; 10(3):297-306. PubMed ID: 5104497
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic and non-neuroleptic catalepsy.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1973 May; 23(5):674-83. PubMed ID: 4740210
    [No Abstract]   [Full Text] [Related]  

  • 3. Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain.
    Costall B; Naylor RJ; Olley JE
    Neuropharmacology; 1972 Sep; 11(5):645-63. PubMed ID: 4597256
    [No Abstract]   [Full Text] [Related]  

  • 4. Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy.
    Maj J; Mogilnicka E; Przewlocka B
    Pharmacol Biochem Behav; 1975; 3(1):25-7. PubMed ID: 1168927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of theophylline and caffeine on neuroleptic-induced catalepsy.
    Maj J; Rawlów A; Sarnek J
    Pol J Pharmacol Pharm; 1976; 28(6):571-8. PubMed ID: 1034921
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible importance of 5-hydroxytryptamine in neuroleptic-induced catalepsy in rats [proceedings].
    Carter CJ; Pycock CJ
    Br J Pharmacol; 1977 Jun; 60(2):267P-268P. PubMed ID: 560233
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cataleptigenic activities of nicotine in the mouse].
    Timsit J
    Therapie; 1967; 22(6):1293-306. PubMed ID: 5627093
    [No Abstract]   [Full Text] [Related]  

  • 8. The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents.
    Costall B; Naylor RJ
    Neuropharmacology; 1974 May; 13(5):353-64. PubMed ID: 4607196
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonergic involvement with neuroleptic catalepsy.
    Costall B; Fortune DH; Naylor RJ; Mardsen CD; Pycock C
    Neuropharmacology; 1975 Nov; 14(11):859-68. PubMed ID: 1239697
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of different tests for evaluation of catalepsy in rats].
    Simon P; Langwinski R; Boissier JR
    Therapie; 1969; 24(6):985-95. PubMed ID: 5392109
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cataleptigenic activity of several neuroleptics and parasympathomimetics in the mouse].
    Timsit J
    Therapie; 1967; 22(4):885-93. PubMed ID: 6070453
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholinergic and neuroleptic induced catalepsy: modification by lesions in the globus pallidus and substantia nigra.
    Costall B; Olley JE
    Neuropharmacology; 1971 Sep; 10(5):581-94. PubMed ID: 5166621
    [No Abstract]   [Full Text] [Related]  

  • 13. Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudate-putamen.
    Yoshida Y; Ono T; Kawano K; Miyagishi T
    Brain Res; 1994 Mar; 639(1):139-48. PubMed ID: 7910107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.
    Kaakkola S; Ahtee L
    Psychopharmacology (Berl); 1977 Mar; 52(1):7-15. PubMed ID: 403561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy.
    Maj J; Sowińska H; Baran L
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):197-203. PubMed ID: 945050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased sensitivity to neuroleptics in rats with lesions of the central nervous system.
    Delini-Stula A
    Psychopharmacologia; 1972; 26(1):84-90. PubMed ID: 5065892
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology of schizophrenia and the striatum.
    Klawans HL; Goetz C; Westheimer R
    Dis Nerv Syst; 1972 Nov; 33(11):711-9. PubMed ID: 4266033
    [No Abstract]   [Full Text] [Related]  

  • 18. Intrastriatal injection of quaternary butyrophenones and oxypertine: neuroleptic effect in rats.
    Fog R; Randrup A; Pakkenberg H
    Psychopharmacologia; 1971; 19(3):224-30. PubMed ID: 5105727
    [No Abstract]   [Full Text] [Related]  

  • 19. Modification of the behavioural changes induced by haloperidol in the ray by lesions in the caudate nucleus, the caudate-putamen and globus pallidus.
    Naylor RJ; Olley JE
    Neuropharmacology; 1972 Jan; 11(1):81-9. PubMed ID: 5062184
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: a potential treatment for extrapyramidal syndromes.
    González-Lugo OE; Ceballos-Huerta F; Jiménez-Capdeville ME; Arankowsky-Sandoval G; Góngora-Alfaro JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1465-71. PubMed ID: 20713114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.